Viva_Viet
SENIOR MEMBER
- Joined
- Jun 26, 2011
- Messages
- 7,503
- Reaction score
- -6
- Country
- Location
Wow, your analyst is really impressed.Okay, I just went through chapter 8 (only chapter 8) Technical Barriers to Trade Chapter, all 38 pages of it, here is my thought
1. The chapter mainly focus on establishing procedure to increase clarity on procedures for evaluationing technical barrier, not eliminating the barrier outright. (Which is understandable since the whole IP section of the deal is focused on restricting outward flow of technology via patenting rights)
2. The chapter also spent a lot of efforts providing suggestions for cooperation in establishing technical standards and procedures. This has broader impact as the chapter also suggest that all party involved should endeavor to share the standards and procedures as soon as possible with WTO members.
3. There will be a committee forming in regulating tech barrier within the year, we will need to wait and see their performance.
4. Specific item regarding to several items are discussed:
Wine: (Focusing on proper labeling of product related information, such as alcohol content, production origin)
Information and Communication Technology (ICT) Products that Use Cryptography: (Specifically, no party is allowed to impose regulations to force transfer of technology, also, it is stated that "If a Party requires positive assurance that an ITE product meets a standard or technical regulation for electromagnetic compatibility, it shall accept a supplier's declaration of conformity.")
Pharmaceuticals: "no Party shall require sale or related financial data concerning the marketing of the product as part of such a determination (of whether to authorize the release of certain pharmaceuticals to the local market)"
"Where a Party requires periodic reauthorisation for a pharmaceutical product that has previously received marketing authorisation by the Party, the Party shall allow the pharmaceutical product to remain on its market under the conditions of the previous marketing authorisation pending its decision on the periodic reauthorisation, except where a Party identifies a significant health or safety concern."
There are also additional lines ensuring that local government cannot impede market presence of certain pharmaceutical products unless it can cite major health concerns. I wouldn't clog up the lines with the quotes, but it is a rather interesting read.
Cosmetics: Pretty much the same thing for Pharmaceuticals
Medical Devices: Pretty much the same thing for Pharmaceuticals
Proprietary Formulas for prepackaged foods and food additives: Even if a local party gathers secret information regarding to a certain product, it may only use such information in administrative and legal procedures while maintaining its confidentiality.
Organic Products: Individual parties are encouraged to accept equivalent standards from other parties and if they do not, they "shall", on request, explain their reasons.
TLDR version, here is my thought on technical barrier section:
JESUS CHRIST, HOW MUCH DID THE BIG PHARMA, COSMETICS AND MEDICAL PRODUCERS LOBBY FOR THIS? As expected from the preliminary leak, TTP is indeed mostly about protecting existing IP and by extension, facilitate trade while maintaining technical barriers. While the other agreements are pretty tame and mundane. The section concerning pharmaceutical, cosmetics and medical devices give unparalleled power to current patent holders in regarding to other markets.
Not only there are specific guidelines preventing local governments from assess the cost, product procedure and assess related technical information, it also have specific guidelines preventing local government from suspending or preventing the presences of foreign products from flooding the local market. Guess which one will benefit which.
When I have time, I will read the other chapters and make observation as well, but I suspect it will be similar. Someone read on section concerning Japan-US agriculture/automobile trade, that section will be important as well.
Base on TPP text transated and analysed into VNese, TPP deal will create a win-win deal btween TPP members, but each TPP member need to retructure to fit with TPP rules.
So, I think US pharma will not flood the small VN market( dont know if they do the same to JP), they need to sit and talk wt us if we feel unhappy wt their pharma, medical.